Search Results

69,705 Results for "actelion ltd".

Sort By

Press Releases

NeuroPace Completes Repurchase of 5.3 Million Shares of Its Common Stock from KCK Ltd.

February 21, 2025
·
4 min read
Press Releases

BlackfinBio Ltd announces the acquisition of Parkinson’s IP patent portfolio from OXB

January 8, 2025
·
1 min read
Press Releases

WORK Medical Technology Group LTD’s Subsidiary, Hangzhou Shanyou, Showcases Products at MEDICA Trade Fair 2024

November 28, 2024
·
4 min read
Press Releases

Medicus Pharma Ltd. Enters into Standby Equity Purchase Agreement and Announces Intention to Voluntarily Delist from the TSX Venture Exchange (TSXV)

February 11, 2025
·
6 min read
Press Releases

AI/ML Innovations Closes Acquisition of Quantum Sciences Ltd.

December 24, 2024
·
8 min read
Press Releases

AI/ML Innovations to Acquire Quantum Sciences Ltd

December 10, 2024
·
4 min read
Press Releases

Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc.

January 24, 2025
·
5 min read
Deals

Juvisé Pharmaceuticals Acquires Multiple Sclerosis Drug PONVORY® (ex-US/Canada) and Opens Its Capital to Bpifrance and Pemberton

The French pharmaceutical company, Juvisé Pharmaceuticals, announces the acquisition of global commercial rights (excluding the United States and Canada) to Ponvory® (ponesimod) from Actelion Pharmaceuticals Ltd., a Johnson & Johnson Company (Johnson & Johnson). Ponvory® is indicated for the treatment of adults with active forms of relapsing multiple sclerosis (RMS); it is protected by several patents, the latest of which expires in 2035.

March 26, 2024
·
4 min read
Press Releases

Portage Biotech Announces Letter of Intent with Immunova for an Option to Acquire iOx Therapeutics, Ltd

December 18, 2024
·
4 min read
Press Releases

Meiji Seika Pharma: Announcement of the Establishment of Local Subsidiary “Taiwan Meiji Pharma Co., Ltd.” in Taiwan

December 25, 2024
·
1 min read